COX-2 and the cyclopentenone prostaglandins - a new chapter in the book of inflammation?
- 30 June 2000
- journal article
- review article
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 62 (1), 33-43
- https://doi.org/10.1016/s0090-6980(00)00074-5
Abstract
No abstract availableThis publication has 74 references indexed in Scilit:
- Allergic lung responses are increased in prostaglandin H synthase–deficient miceJCI Insight, 1999
- The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiationBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury.JCI Insight, 1995
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factorCell, 1994
- Heat shock proteins and virus replication: hsp70s as mediators of the antiviral effects of prostaglandinsCellular and Molecular Life Sciences, 1994
- Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.JCI Insight, 1993
- NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesionsGeneral Pharmacology: The Vascular System, 1993
- Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin ResistanceScience, 1993
- Metabolism of prostaglandin F2 alpha in Zellweger syndrome. Peroxisomal beta-oxidation is a major importance for in vivo degradation of prostaglandins in humans.JCI Insight, 1991
- Prostaglandin A Compounds as Antiviral AgentsScience, 1980